India to Belgium: Lenalidomide Export Trade Route
India has recorded 88 verified shipments of Lenalidomide exported to Belgium, representing a combined trade value of $2.5M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $28.9K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 51% of total export value with 65 shipments worth $1.3M USD. On the buying side, YUSEN LOGISTICS BENELUX BELGIUM is the largest importer in Belgium with $1.3M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Belgium Lenalidomide corridor is one of India's established pharmaceutical export routes, with 88 shipments documented worth a combined $2.5M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's lenalidomide manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $28.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with lenalidomide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 17.9%, placing it at rank #13 among India's top lenalidomide export destinations globally.
On the import side, key buyers of Indian lenalidomide in Belgium include YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM , YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN and 1 others. YUSEN LOGISTICS BENELUX BELGIUM is the single largest importer with 56 shipments valued at $1.3M USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ1
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#13
- Annual growth+17.9%
- Demand growth+17.3%
- Regulatory ease83/100
Top 10 Indian Lenalidomide Exporters to Belgium
Showing top 10 of 2 Indian suppliers exporting Lenalidomide to Belgium, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $20.1K per shipment | 65 | $1.3M | 51.5% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $53.6K per shipment | 23 | $1.2M | 48.5% |
This table shows the top 10 of 2 Indian companies exporting lenalidomide to Belgium, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 65 shipments worth $1.3M USD, giving it a 51% market share.
Top 10 Lenalidomide Importers in Belgium
Showing top 10 of 4 known buyers in Belgium receiving Lenalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lenalidomide in Belgium include YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM , YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, KEETBERGLAAN 2. The largest importer is YUSEN LOGISTICS BENELUX BELGIUM, accounting for $1.3M USD across 56 shipments — representing 50% of all lenalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUM | 56 | $1.3M | 50.4% |
| 2 | YUSEN LOGISTICS BENELUX BELGIUM | 23 | $1.2M | 48.5% |
| 3 | YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | 6 | $15.6K | 0.6% |
| 4 | KEETBERGLAAN 2 | 3 | $11.3K | 0.4% |
Top 10 Lenalidomide Formulations Imported by Belgium
Showing top 10 of 78 product formulations shipped on the India to Belgium Lenalidomide route, ranked by trade value
Belgium imports a wide range of lenalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LENALIDOMIDE CAPS 7.5MG 3X7'S GERMANY PA — accounts for $221.5K USD across 1 shipments. There are 78 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LENALIDOMIDE CAPS 7.5MG 3X7'S GERMANY PA | 1 | $221.5K | 8.7% |
| 2 | LENALIDOMIDE CAPS 5MG 3X7'S UK, PACK : 3x7s, Batch : HAG0123D MFD : 12.01.2025 EXP : 31.12.2026 | 1 | $213.1K | 8.4% |
| 3 | LENALIDOMIDE CAPS 10MG 3X7'S GERMANY PAC | 2 | $212.3K | 8.4% |
| 4 | LENALIDOMIDE CAPSULES 5MG [8961 PACK X 3X7'S]NOS | 3 | $145.2K | 5.7% |
| 5 | LENALIDOMIDE CAPSULES 7.5MG [5381 PACK X3X7'S] | 1 | $135.3K | 5.3% |
| 6 | LENALIDOMIDE CAPS 10MG 3X7S UK PACK : 3 | 1 | $116.0K | 4.6% |
| 7 | LENALIDOMIDE CAPS 20MG 3X7'S GERMANY PAC | 2 | $115.7K | 4.6% |
| 8 | LENALIDOMIDE CAPS 10MG 3X7'S UK PACK : 3 | 3 | $112.4K | 4.4% |
| 9 | LENALIDOMIDE CAPS 25MG -GST INVOICE NO. EI2424001709 DT.25.03.2025 | 1 | $89.4K | 3.5% |
| 10 | LENALIDOMIDE CAPS 7.5MG 3X7'S UK PACK : | 1 | $88.8K | 3.5% |
Showing top 10 of 78 Lenalidomide formulations imported by Belgium on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 31 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's lenalidomide exports to Belgium are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 65 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Belgium benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $28.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as lenalidomide caps 5mg 3x7's uk, pack : 3x7s, batch : hag0123d mfd : 12.01.2025 exp : 31.12.2026 and lenalidomide caps 10mg 3x7's germany pac , suggesting that buyers in Belgium tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, YUSEN LOGISTICS BENELUX BELGIUM is the largest importer with 56 shipments worth $1.3M USD — representing 50% of all lenalidomide imports from India on this route.
Route Statistics
- Trade Volume
- $2.5M
- Avg. Shipment
- $28.9K
- Suppliers
- 2
- Buyers
- 4
- Transit (Sea)
- ~24 days
- Annual Growth
- +17.9%
Related Analysis
Other Lenalidomide Routes
Unlock the Full India to Belgium Lenalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 88 shipments on this route.
Frequently Asked Questions — India to Belgium Lenalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lenalidomide to Belgium?
The leading Indian exporters of Lenalidomide to Belgium are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 51% of total trade value on this route.
Q What is the total value of Lenalidomide exports from India to Belgium?
India exports Lenalidomide to Belgium worth approximately $2.5M USD across 88 recorded shipments. The average value per shipment is $28.9K USD.
Q Which ports does India use to ship Lenalidomide to Belgium?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 31 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Belgium for Lenalidomide?
The average transit time for Lenalidomide shipments from India to Belgium is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Belgium Lenalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.9% with demand growth tracking at 17.3%. The route is ranked #13 among India's top Lenalidomide export destinations globally.
Q How many suppliers are active on the India to Belgium Lenalidomide route?
There are currently 2 active Indian suppliers exporting Lenalidomide to Belgium. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 51% of total shipment value.
Q Who are the main importers of Lenalidomide from India in Belgium?
The leading importers of Indian Lenalidomide in Belgium include YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM , YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN, KEETBERGLAAN 2. YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer with 56 shipments worth $1.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Belgium export trade corridor identified from Indian Customs (DGFT) records for Lenalidomide.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 4 importers in Belgium matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 88 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
88 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists